Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON®) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: An open-label, multicentre, single-treatment-arm study

Gavin R. Graff, John McNamara, James Royall, Steven Caras, Kristin Forssmann

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint Dive into the research topics of 'Safety and tolerability of a new formulation of pancrelipase delayed-release capsules (CREON®) in children under seven years of age with exocrine pancreatic insufficiency due to cystic fibrosis: An open-label, multicentre, single-treatment-arm study'. Together they form a unique fingerprint.

Medicine & Life Sciences